Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL)
| 17.67 Delayed Data As of 3:59pm ET |  +0.52 / +3.03%Today’s Change | 15.55 Today|||52-Week Range 52.85 | -12.26% Year-to-Date |
Latest ZNTL News | Press Releases
No recent news for Zentalis Pharmaceuticals Inc.
Today’s Trading
| Previous close | 17.15 |
| Today’s open | 17.38 |
| Day’s range | 17.38 - 17.99 |
| Volume | 12,308 |
| Average volume (3 months) | 549,039 |
| Market cap | $1.0B |
Data as of 3:59pm ET, 03/27/2023
Growth & Valuation
| Earnings growth (last year) | -20.49% |
| Earnings growth (this year) | +8.93% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.34 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | May 4, 2023 |
| EPS forecast (this quarter) | -$0.97 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$236.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
